MSB 3.21% $1.13 mesoblast limited

okay but why. simply prioritising on most likely/timely...

  1. 647 Posts.
    lightbulb Created with Sketch. 319
    okay but why.
    simply prioritising on most likely/timely approval
    too distracting.
    lack of a capacity.
    not a good look (with fda or investors)

    does that mean the meeting will be delayed again till gvhd is not in front of them.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.